Bispecific antigen binding molecules targeting ox40 and fap

The invention relates to novel bispecific antigen binding molecules, comprising at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP), and to methods of producing these molec...

Full description

Saved in:
Bibliographic Details
Main Authors BACHL, JUERGEN PETER, BUJOTZEK, ALEXANDER, STAACK, ROLAND, RUEGER, PETRA, MARRER-BERGER, ESTELLE, POUSSE, LAURENE, SAM, JOHANNES, TUERCK, DIETRICH, CANTRILL, CARINA, MOESSNER, EKKEHARD, AMANN, MARIA, DUERR, HARALD, IMHOF-JUNG, SABINE, KLEIN, CHRISTIAN, ZIELONKA, JOERG, FAIGLE, JANINE, KRAFT, THOMAS, UMANA, PABLO
Format Patent
LanguageChinese
English
Published 01.08.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to novel bispecific antigen binding molecules, comprising at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP), and to methods of producing these molecules and to methods of using the same.
Bibliography:Application Number: TW202110111809